Friday 17 September
The Role of Biomarkers in Patient Management in Immuno-Oncology
Friday, 10:30 - 11:30
View the satellite invitation
Unmet Needs in Oncogene-Driven NSCLC: How Do We Close the Gap?
Friday, 10:30 – 12:00
View the satellite invitation
Evolving Treatment Landscape in HNSCC
Friday, 18:45 - 20:15
View the satellite invitation
Saturday 18 September
Expert Perspectives in ALK+NSCLC: A Round Table Discussion
Saturday, 08:45 – 09:45
View the satellite invitation
Precision Therapy in NSCLC: The Dawn of KRASG12C Inhibition
Saturday, 10:30 – 12:00
View the satellite invitation
Advances in Antibody Drug Conjugates in Solid Tumors: Current Treatments and Emerging Therapies
Saturday, 18:45 - 20:15
View the satellite invitation
Janssen Satellite Symposium on EGFR-Positive NSCLC
Saturday, 18:45 – 20:15
View the satellite invitation
Illuminating the Path Forward in EGFR Exon20 Insertion+ mNSCLC: Unmet Needs and the Evolving Treatment Landscape
Saturday, 18:45 – 20:15
View the satellite invitation
Sunday 19 September
Personalising and Optimising Treatment for Metastatic NSCLC Patients With EGFR and Other Co-Occurring Mutations
Sunday, 10:30 - 12:00
View the satellite invitation
A New Breath in Lung Cancer
Sunday, 10:30 - 12:00
View the satellite invitation
CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
Sunday, 18:45 - 20:15
View the satellite invitation
Monday 20 September
Emerging Immuno-Oncology Options in Metastatic NSCLC and SCLC: Clinical Evidence and Future Perspectives
Monday, 10:30 - 12:00
View the satellite invitation
I-O Revolution: New Perspectives in the Treatment of Thoracic Cancers
Monday, 18:45 - 20:15
View the satellite invitation
Optimizing Immuno-Oncology in NSCLC: What Do We Know and Where Should We Go?
Monday, 18:45 - 20:15
View the satellite invitation
Tuesday 21 September
Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors
Tuesday, 10:30 - 12:00
View the satellite invitation
Rapid Progress During a Pandemic: Emerging Therapeutic Options for NSCLC
Tuesday, 10:30 – 12:00
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.
View the complete ESMO Congress 2021 Industry Sponsored Satellite Symposia Programme